Could a quick blood thinner before stroke surgery boost recovery?

NCT ID NCT07135089

Recruiting now Disease control Sponsor: General Hospital of Shenyang Military Region Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving the blood-thinning drug tirofiban before a clot-removal procedure helps people recover better after a stroke caused by a blocked artery. About 870 adults with a large-vessel stroke will receive either tirofiban or a placebo before the procedure. The main goal is to see if more people can live independently 90 days later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tirofiban (a blood-thinning drug given intravenously)
What this could lead to: If it works, this could provide a new way to reduce disability after stroke by giving a clot-preventing drug right before the clot-removal procedure.
What could go wrong: This is a large phase 3 trial, but it is still testing an unproven approach. The drug may increase bleeding risk, and the benefit may be small or not apply to all stroke patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL ATHEROSCLEROSIS WITH ANTERIOR CIRCULATION LARGE VESSEL OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke large artery stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE, ISCHEMIC

Contacts and locations

Locations

General Hospital of Northern Theater Command
RECRUITING

Shenyang, Liaoning, 110016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.